TP53 and acute myeloid leukemia: Moreover, TP53 genetic abnormalities are extremely rare in NPM1-mutated AML [25, 26], implying that signals downstream of nucleolar stress response are preserved in leukemic cells, further supporting the use of dactinomycin in this setting.